Foghorn therapeutics inc.

Major-Pharmaceuticals

FHTX


Executive/
Director

Price

  • Last Close
  • $ 4.8
    $ +0.18 3.9 %
    Jan 3, 2025
  • 52-Week High/Low
  • $8.39 - $2.82
  • YTD
  • 1.5%

  • Trading Volume
  • 12,342
  • Market Cap Full
  • $ 202.6M
  • Shares Outstanding
  • 42.2M
    Oct 31, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - - -5% -35% -34.3% -2.8% 4.2% 1.5%
Q2 - - - - 4% -19% -11.5% 13.6% -19.7% -
Q3 - - - - 8% 30.6% -36.9% -29% 10.6% -
Q4 - - - - 11.9% 67.7% -25.6% 45.3% -49.1% -
J F M A M J J A S O N D
2025 1.5% - - - - - - - - - - -
2024 -50.7% 143.1% -13.1% -19.9% 9.1% -2% 22.6% 10.6% - - - -40.8%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%0%0%15%-73%1%-27%1%

Earnings

2020 2021 2022 2023
Q1 - -0.62 -0.65 -0.73
Q2 - -0.63 -0.66 -0.70
Q3 - -0.71 -0.62 -0.34
Q4 - -0.77 -0.69 -
A -6.2 -2.7 -2.6 -1.77

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2020 2021 2022 2023
Mar - 36.8 41.4 41.8
Jun - 36.8 41.5 41.8
Sep - 36.9 41.6 41.9
Dec 35.8 37.1 41.8 42.2

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 1 0.1 - - -
Total Asset Turnover 0.1 - - - -
Leverage
Debt Ratio - - 0.1 0.7 -
Debt – Equity Ratio - - 0.1 -11 -
Interest Coverage 14.6 - - - -
Equity multiplier - 0.2 0.2 -5 -